Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Gossamer Bio Inc (GOSS)

  • Technical Exchange News
  • March 04, 2024, 18:34 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Technical Exchange News
  • March 04, 2024, 18:34 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Computer Programs and Systems Inc (CPSI)

  • Technical Exchange News
  • March 04, 2024, 00:21 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Computer Programs and Systems, Inc. - Common Stock.

Comment Full text

Computer Programs and Systems Inc (CPSI)

  • Technical Exchange News
  • March 04, 2024, 00:21 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Computer Programs and Systems, Inc. - Common Stock. New value: Computer Programs and Systems, Inc. - Common Stock.

Comment Full text

Computer Programs and Systems Inc (CPSI)

  • Technical Exchange News
  • March 04, 2024, 00:21 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Computer Programs and Systems, Inc. - Common Stock.

Comment Full text

Sangamo Therapeutics Inc (SGMO)

  • Technical Exchange News
  • March 01, 2024, 18:56 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mink Therapeutics Inc (INKT)

  • Technical Exchange News
  • March 01, 2024, 18:56 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Eterna Therapeutics Inc (ERNA)

  • Technical Exchange News
  • March 01, 2024, 18:55 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Entera Bio Ltd. (ENTX)

  • Technical Exchange News
  • March 01, 2024, 18:55 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Precision BioSciences (DTIL)

  • Technical Exchange News
  • March 01, 2024, 18:55 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 779
  • 780
  • 781
  • 782
  • 783
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250711)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150036)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin